The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
Day One Biopharmaceuticals, Inc. Common Stock 23954D109   45,333,312 6,430,257 SH   SOLE   6,430,257 0 0
Disc Medicine, Inc. Common Stock 254604101   141,584,131 2,142,617 SH   SOLE   2,142,617 0 0
Dyne Therapeutics, Inc. Common Stock 26818M108   115,500,382 9,130,465 SH   SOLE   9,130,465 0 0
Generation Bio, Co. Common Stock 37148K100   5,067,030 827,946 SH   SOLE   827,946 0 0
ImageneBio, Inc. Common Stock 45175G207   3,079,184 377,814 SH   SOLE   377,814 0 0
Korro Bio, Inc. Common Stock 500946108   54,458,066 1,137,149 SH   SOLE   1,137,149 0 0
Kymera Therapeutics, Inc. Common Stock 501575104   277,139,749 4,896,462 SH   SOLE   4,896,462 0 0
Q32 Bio, Inc. Common Stock 746964105   4,142,370 2,092,106 SH   SOLE   2,092,106 0 0
Sionna Therapeutics, Inc. Common Stock 829401108   106,332,649 3,615,527 SH   SOLE   3,615,527 0 0